We are international

ASH 2012

The 54th Annual Meeting of the American Society of Hematology (ASH) took place at the Georgia World Congress Center in Atlanta, Georgia from December 8-11, 2012. The webcasts taped at the meeting are reports on the current status of some of the most interesting research in myeloma. Please be aware that at the time of posting, in some cases, the interviewees are reporting on interim data from incomplete clinical trials. Therefore not all the data presented are final results, and it is possible that results will be different when the data has matured with long-term follow-up. None of this research has yet been peer-reviewed and published in a medical journal.

There are over 60 interviews available, organized by subject area under the tabs shown below, appearing with a picture of the presenter and the title of the presentation. You can click on any of the interviews to view the details. Each interview has the text of the abstract (summary) under the Text tab. The slides or poster where available are under the PDF tab. Videos appear under the MULTIMEDIA tab.


International Overviews
Proteasome Inhibitors
Immunomodulatory Drugs (IMids)
Other Novel Agents
Genetic Studies
Second Primary Malignancies
Best of ASH 2012 Teleconference:
What Patients Need to Know

Recorded January 17, 2013
with Dr. Brian G. M. Durie

ASH 2012: Dr. Gertz - An Overview of ASH
Morie Getz, MD
Mayo Clinic
Rochester, Minnesota, USA

ASH 2012: Dr. Durie- Overview
Brian Durie, MD
Cedars Sinai Comprehensive Cancer Center
Los Angeles, CA
ASH 2012: Dr. Anderson's ASH Overview
Ken Anderson, MD
Dana Farber Cancer Institute
Boston, Massachusetts

"Controversies in Multiple Myeloma: Current Debates in Optimal Care"
Live Streamed December 7, 2012 from 1:00-4:00 p.m. EST
from the 2012 ASH Annual Meeting and Exposition in Atlanta, Georgia